Clinical trials
Phase 1 Leukemia, Myeloid, Acute trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 7 |
| 2019 | 3 |
| 2020 | 8 |
| 2021 | 6 |
| 2022 | 13 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 59 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 3 |
| iCell Gene Therapeutics | 3 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 2 |
| Nantes University Hospital | 2 |
| University of Sydney | 2 |
| Xinqiao Hospital of Chongqing | 2 |
| Zhejiang University | 2 |
| Zhongnan Hospital | 2 |
| 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 59 |
| Myelodysplastic Syndromes | 13 |
| Leukemia | 11 |
| Recurrence | 8 |
| Lymphoma, Non-Hodgkin | 6 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 6 |
| Multiple Myeloma | 5 |
| Myeloproliferative Disorders | 5 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Hematologic Neoplasms | 3 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.